NCT04087200 (PRATO-ACS) is a clinical trial in Acute Coronary Syndrome, sponsored by Centro Cardiopatici Toscani.

Who is sponsoring NCT04087200?

NCT04087200 is sponsored by Centro Cardiopatici Toscani.

What condition does NCT04087200 study?

NCT04087200 studies Acute Coronary Syndrome.

Is NCT04087200 still recruiting?

NCT04087200 is currently recruiting now. Last updated 12 September 2019.

Last reviewed 2019-09-12 · How we verify

NCT04087200: PRATO-ACS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome

Recruiting now Last updated 12 September 2019

What this trial tests

trial in Acute Coronary Syndrome in 2,500 participants. Currently enrolling.

Timeline

1 December 2016

Primary endpoint
1 December 2025

1 December 2026

Quick facts

Lead sponsor	Centro Cardiopatici Toscani
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,500
Start date	1 December 2016
Primary completion	1 December 2025
Estimated completion	1 December 2026
Sites	1 location across Italy

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →

Sponsor

Centro Cardiopatici Toscani

Who can join

Eligibility, any sex, with Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Biomarkers of residual risk and all-cause mortality after acute coronary syndrome.
Toso A, Leoncini M, Maioli M, Villani S, et al · · 2025 · cited 5× · PMID 39896052 · DOI 10.1016/j.ajpc.2025.100934

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04087200 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centro Cardiopatici Toscani
Last refreshed: 12 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04087200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing